PMC:7283670 / 107929-108009 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T16","span":{"begin":37,"end":45},"obj":"Body_part"}],"attributes":[{"id":"A16","pred":"fma_id","subj":"T16","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"Tocilizumab vs CRRT in management of cytokine release syndrome (CRS) in COVID‐19"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T566","span":{"begin":64,"end":67},"obj":"Disease"},{"id":"T568","span":{"begin":72,"end":80},"obj":"Disease"}],"attributes":[{"id":"A566","pred":"mondo_id","subj":"T566","obj":"http://purl.obolibrary.org/obo/MONDO_0007399"},{"id":"A567","pred":"mondo_id","subj":"T566","obj":"http://purl.obolibrary.org/obo/MONDO_0017361"},{"id":"A568","pred":"mondo_id","subj":"T568","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Tocilizumab vs CRRT in management of cytokine release syndrome (CRS) in COVID‐19"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T298","span":{"begin":37,"end":62},"obj":"Phenotype"}],"attributes":[{"id":"A298","pred":"hp_id","subj":"T298","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"Tocilizumab vs CRRT in management of cytokine release syndrome (CRS) in COVID‐19"}